Genscript Biotech Corporation (GNNSF)
OTCMKTS · Delayed Price · Currency is USD
2.070
+0.400 (23.95%)
Jul 18, 2025, 4:00 PM EDT

Genscript Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
4,5632,7165,3986,7419,2972,842
Upgrade
Market Cap Growth
-51.40%-49.68%-19.93%-27.49%227.16%-33.34%
Upgrade
Enterprise Value
4,6662,4344,8676,1148,3031,914
Upgrade
Last Close Price
2.121.272.442.964.551.41
Upgrade
PE Ratio
1.540.92----
Upgrade
PS Ratio
7.674.579.6310.7718.977.27
Upgrade
PB Ratio
1.060.632.644.956.703.48
Upgrade
P/TBV Ratio
1.060.633.946.859.253.30
Upgrade
P/OCF Ratio
60.3135.90----
Upgrade
EV/Sales Ratio
7.934.098.689.7716.944.90
Upgrade
EV/EBITDA Ratio
102.6534.7558.29---
Upgrade
EV/EBIT Ratio
-262.23185.81---
Upgrade
EV/FCF Ratio
-38.84-----
Upgrade
Debt / Equity Ratio
0.170.170.410.480.300.07
Upgrade
Debt / EBITDA Ratio
8.518.518.59---
Upgrade
Asset Turnover
0.140.140.190.260.270.34
Upgrade
Inventory Turnover
7.647.645.126.175.465.60
Upgrade
Quick Ratio
2.462.464.502.993.802.85
Upgrade
Current Ratio
2.722.724.763.233.973.03
Upgrade
Return on Equity (ROE)
-5.46%-5.46%9.56%-31.12%-47.05%-47.38%
Upgrade
Return on Assets (ROA)
0.13%0.13%0.55%-11.45%-12.88%-10.94%
Upgrade
Return on Capital (ROIC)
0.15%0.15%0.67%-14.32%-17.72%-20.18%
Upgrade
Return on Capital Employed (ROCE)
0.20%0.20%0.90%---
Upgrade
Earnings Yield
64.92%109.05%-1.77%-3.36%-3.86%-7.21%
Upgrade
FCF Yield
-2.63%-4.42%-9.99%-4.99%-2.90%-9.61%
Upgrade
Buyback Yield / Dilution
-3.37%-3.27%-0.58%-3.28%-6.83%-2.53%
Upgrade
Total Shareholder Return
--3.27%-0.58%-3.28%-6.83%-2.53%
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.